Skip to main content

Table 1 Study characteristics of included primary studies

From: Effects of oncological care pathways in primary and secondary care on patient, professional and health systems outcomes: a systematic review and meta-analysis

 

Study ID

Study design

Tumor location

Sample Size

Country

Setting

1

Chen et al. 2000 [20]

Non-randomized controlled triala (with a historical control group)

Unilateral neck dissection

190

USA

Academic cancer Center, secondary/tertiary care

2

Dahl et al. 2017 [25]

Non-randomized controlled triala (with a historical control group)

Cancer patients (colorectal, lung, melanoma, breast, prostate, and other)

3292

Denmark

Danish hospitals, primary and secondary care

3

Gendron et al. 2002 [21]

Interrupted time series studya

Head and neck cancer surgery

212

USA

Tertiary care academic medical center

4

Ghosh et al. 2001 [22]

Interrupted time series studya

Hysterectomy cervical or endometrial cancer

151

USA

Academic Medical Center, tertiary care

5

Jeong et al. 2011 [23]

Non-randomized controlled triala

Treatment of gastric cancer (early vs. advanced; non-CP vs. CP)

631

Korea

Unclear, secondary care

6

Kiyama et al. 2003 [18]

Randomized controlled trial

Gastric cancer

85

Japan

Nippon Medical School Hospital, secondary care

7

Tastan et al. 2012 [24]

Non-randomized controlled triala

Breast cancer

69

Turkey

Military Medical Academy, secondary care

8

Williams et al. 2015 [19]

Randomized controlled trial

Pain screening and treatment in head and neck cancer

156

UK

Hospital, secondary care

  1. USA United States of America, CP care pathway, UK United Kingdom
  2. aStudy design is not mentioned in the article; specification is based on the Cochrane study designs